IP Library › Patent Application 17027761
Patent Application
App. No. 17/027,761

SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/027,761
Abstract

The invention provides methods and compositions for treating cancers and myeloproliferative disorders using sphingosine kinase-1 inhibitors, such as SK1-I, and selective sphingosine-1-phosphate receptor agonists, such as ozanimod.

Claims (5)

1 . A method for treating prostate cancer in a mammalian subject, comprising the step of:

administering to a mammalian subject in need of treatment for prostate cancer an effective amount of ozanimod or a pharmaceutically acceptable salt thereof.

2 . The method of claim 1 , wherein the administering step comprises administering the hydrochloride salt of ozanimod to the mammalian subject.

3 . The method of claim 1 , wherein the mammalian subject is a human.

4 . The method of claim 3 , wherein the administering step comprises administering the hydrochloride salt of ozanimod to the mammalian subject.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2020
From: RABBANI, ELAZAR; DONEGAN, JAMES J.; DIAMOND, PAUL
To: ENZO BIOCHEM, INC.
Reel/Frame 054203/0039 →